How Innovative Financing Mechanisms are Utilized in Global Health Programs Among International Organizations: A Qualitative Research

Abstract

The COVID-19 pandemic, global economic downturns, and shifting geopolitical priorities have significantly impacted funding for global health programs, with resources increasingly redirected toward domestic needs and other global challenges. Traditional funding mechanisms, primarily bilateral and multilateral aid, face growing challenges, including political susceptibility and rigid allocation structures. This study examines how international organizations leverage innovative financing mechanisms to complement traditional funding approaches in global health.Using a qualitative research design, the study conducted semi-structured interviews with eleven senior experts from major global health organizations between May and July 2024, employing purposive and snowball sampling methods. Data analysis followed a systematic coding process using NVivo 14, with member checking and peer debriefing enhancing methodological rigor. Findings reveal three key trends in the adoption of innovative financing: (1) a shift from direct funding to structured risk-sharing mechanisms, such as performance-based financing and contingent grants, (2) the evolving role of stakeholder relationships, where partnerships extend beyond traditional donors to include private investors, development banks, and national governments, and (3) the critical importance of institutional capacity, with effective implementation requiring technical expertise, regulatory frameworks, and governance structures. The study analyzes five major innovative financing mechanisms—Advanced Market Commitments (AMCs), Blended Finance, the International Finance Facility for Immunization (IFFIm), Debt2Health, and Micro-levies. AMCs create incentives for vaccine development by guaranteeing demand, Blended Finance combines public and private funds to de-risk investments, IFFIm leverages bond markets to frontload vaccine financing, Debt2Health converts debt repayments into health investments, and Micro-levies generate sustainable revenue streams through small-scale taxation. The analysis highlights variations in complexity, coordination needs, and risk distribution across these mechanisms. The successful implementation of innovative financing mechanisms depends on several key factors. A clearly defined problem ensures alignment between financial instruments and program objectives. The active engagement of influential stakeholders fosters both commitment and accountability. Additionally, robust risk management frameworks are essential for mitigating financial and operational uncertainties. Rather than replacing traditional funding sources, these mechanisms serve as complementary strategies, with their effectiveness contingent upon institutional structures and local contexts. This research contributes to the discourse on innovative financing in global health by emphasizing the importance of context-specific design and cross-sector collaboration in developing sustainable solutions.